No Data
ECS Botanics Holdings Increases NAB Loan Facility by AU$2.4 Million
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
ECS Botanics Holdings Ltd: ECS Half Year FY25 Results
ECS Botanics Holdings Ltd: Half Yearly Report and Accounts
ECS Botanics' Revenue Falls 33% in Fiscal Q2; Shares Rise 3%
Ecs Botanics Holdings Updates on Securities Cessation
